ReviewDiscover oncology2026
Barriers to fertility preservation among cancer patients in the Middle East and North Africa (MENA) region: a scoping review.
Review in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAdvances in cancer care have increased survival and demand for quality cancer survivorship care. Among survivors of reproductive age, the sequelae of gonadotoxic cancer treatments such as infertility presents a key survivorship and quality-of-life concern. In the Middle East and North Africa (MENA) access to fertility preservation (FP) services is inadequate, limiting future fertility and dreams of childbirth. PURPOSE: To synthesize scientific literature to identify the barriers to FP among cancer patients in the MENA region.
methodsDatabase searches (PubMed, Scopus, Web of Science, Google Scholar, CINAHL, and ProQuest) of articles about FP/oncofertility barriers (January 2015 and June 2025) yielded 243 articles. Articles were included only if they focused on cancer patients or addressed parents and healthcare providers of patients with cancer eligible for FP (n = 22).
resultsContent analysis led to four themes of patient, provider, healthcare system, and socio-cultural related barriers. The key patient-related barriers were lack of knowledge about FP and fear of delaying cancer treatment. The common provider-related barriers were inadequate knowledge and confidence about FP, poor patient teaching, and biases. The main healthcare system barriers were cost and lack of access to FP services. The key social-cultural barriers were the hindrances arising from social norms, cultural values, and religious beliefs about FP.
conclusionCancer patients in the MENA region face complex intersecting barriers to FP. These challenges may differ from one country to another, but require multidisciplinary culturally informed approaches that integrate education, policy reforms, and religious engagement. We highlight future directions to aid equitable access to FP for cancer survivors. IMPLICATIONS FOR PRACTICE: Improving access to FP for cancer patients and survivors in the MENA region requires culturally sensitive, multidisciplinary interventions. Entrenched systems to ensure early FP counseling, provider education and training, and patient education about FP are a reasonable starting point.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.